Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 08:47 am Sale | 2025-12-31 | 13G | CYBIN INC HELP | Deep Track Capital, LP | 2,391,505 4.740% | -680,745 (-22.16%) | Filing History |
| 2026-02-13 08:46 am Sale | 2025-12-31 | 13G | STRUCTURE THERAPEUTICS INC SPO GPCR | Deep Track Capital, LP | 12,335,346 5.950% | -312,087 (-2.47%) | Filing History |
| 2026-02-13 08:45 am Sale | 2025-12-31 | 13G | GERON CORP GERN | Deep Track Capital, LP | 32,511,271 5.090% | -10,488,729 (-24.39%) | Filing History |
| 2026-02-13 08:44 am Sale | 2025-12-31 | 13G | 89BIO INC ETNB | Deep Track Capital, LP | 0 0.000% | -9,356,171 (Position Closed) | Filing History |
| 2026-02-13 08:43 am Purchase | 2025-12-31 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Deep Track Capital, LP | 1,956,867 6.780% | 472,354 (+31.82%) | Filing History |
| 2026-02-13 08:42 am Purchase | 2025-12-31 | 13G | DEFINIUM THERAPEUTICS INC DFTX | Deep Track Capital, LP | 5,676,540 5.540% | 176,540 (+3.21%) | Filing History |
| 2026-02-13 08:41 am Sale | 2025-12-31 | 13G | AKERO THERAPEUTICS INC AKRO | Deep Track Capital, LP | 0 0.000% | -4,400,000 (Position Closed) | Filing History |
| 2026-02-12 4:19 pm Purchase | 2026-02-05 | 13G | BICARA THERAPEUTICS INC BCAX | Deep Track Capital, LP | 2,750,000 5.020% | 2,750,000 (New Position) | Filing History |
| 2026-02-11 4:09 pm Sale | 2026-02-10 | 13G | DYNAVAX TECHNOLOGIES CORP COM DVAX | Deep Track Capital, LP | 0 0.000% | -15,726,349 (Position Closed) | Filing History |
| 2026-02-10 4:38 pm Purchase | 2026-02-05 | 13G | OCULAR THERAPEUTIX INC OCUL | Deep Track Capital, LP | 11,234,132 5.130% | 2,000,000 (+21.66%) | Filing History |
| 2026-02-10 4:30 pm Unchanged | 2025-02-06 | 13D | LB PHARMACEUTICALS INC LBRX | Deep Track Capital, LP | 3,352,804 11.700% | 0 (Unchanged) | Filing History |
| 2026-02-10 09:08 am Sale | 2025-12-31 | 13G | OCULAR THERAPEUTIX INC OCUL | Deep Track Capital, LP | 9,234,132 4.310% | -3,861,723 (-29.49%) | Filing History |
| 2026-02-06 4:00 pm Purchase | 2026-01-30 | 13G | PROMIS NEUROSCIENCES INC N PMN | Deep Track Capital, LP | 902,561 9.990% | 902,561 (New Position) | Filing History |
| 2026-01-30 4:24 pm Purchase | 2026-01-23 | 13G | INVENTIVA SA ADR IVA | Deep Track Capital, LP | 11,668,983 6.070% | 11,668,983 (New Position) | Filing History |
| 2026-01-15 4:13 pm Purchase | 2026-01-08 | 13G | CENTURY THERAPEUTICS INC IPSC | Deep Track Capital, LP | 13,486,400 7.340% | 13,486,400 (New Position) | Filing History |
| 2025-12-01 4:28 pm Purchase | 2025-11-21 | 13G | CORMEDIX INC CRMD | Deep Track Capital, LP | 4,955,487 6.290% | 4,955,487 (New Position) | Filing History |
| 2025-11-21 4:00 pm Purchase | 2025-11-14 | 13G | VERASTEM INC VSTM | Deep Track Capital, LP | 7,719,390 9.990% | 7,719,390 (New Position) | Filing History |
| 2025-11-18 4:01 pm Purchase | 2025-11-11 | 13G | ENGENE HLDGS INC ENGN | Deep Track Capital, LP | 4,317,332 6.690% | 2,077,979 (+92.79%) | Filing History |
| 2025-11-14 08:25 am Sale | 2025-09-30 | 13G | ZURA BIO LTD ZURA | Deep Track Capital, LP | 259,014 0.400% | -4,357,500 (-94.39%) | Filing History |
| 2025-11-14 08:24 am Sale | 2025-09-30 | 13G | TECTONIC THERAPEUTIC INC TECX | Deep Track Capital, LP | 0 0.000% | -1,401,938 (Position Closed) | Filing History |